Eleftha 440mg Injection

Name: Eleftha 440mg Injection
Brand: Vikshar Healthcare Private Limited
Price: 124.91 INR
Availability: InStock

Price 124.91 INR/ Vial

Get a Price/Quote

MOQ : 10 Vials

Eleftha 440mg Injection Specification

Indication
Breast cancer, metastatic gastric cancer

Dosage Form
Injection

Salt Composition
Trastuzumab 440mg

Feature
Prescription only

Ingredients
Trastuzumab lyophilized powder

Application
Hospital, intravenous use

Physical Color/Texture
White to off-white lyophilized powder

Fermentation Smell
Odorless

Storage Instructions
Store at 2-8C, do not freeze

Shelf Life
36 months

Form
Powder for injection

Diluent Provided
Yes

Packaging Type
Vial

Strength
440mg per vial

Administration Route
IV infusion

Prescription/Non prescription
Prescription

Pack Size
1 single-dose vial

Container Material
Glass vial

Reconstitution Required
Yes

Eleftha 440mg Injection Trade Information

Minimum Order Quantity
10 Vials

Supply Ability
1000 Vials Per Month

Delivery Time
7 Days

About Eleftha 440mg Injection

Eleftha 440mg Injection is an acclaimed solution for breast cancer and metastatic gastric cancer management, featuring the popular monoclonal antibody Trastuzumab in a splendid, gilt-edged glass vial. Each excellent single-dose pack contains 440mg reconstitutable powder, tailored for IV infusion and suitable for hospital administration. Odorless with a white to off-white lyophilized texture, this prescription-only medication is supplied with a diluent for reconstitution. Order your packaging confidently, knowing it meets international exporter and trader standards from India. Storage conditions: 2-8C, no freezing, with a 36-month shelf life.

Usage & Applications of Eleftha 440mg Injection

Eleftha 440mg Injection is crafted for hospital use, with its splendid effect majorly in the treatment of breast and metastatic gastric cancer. Administered intravenously, its gilt-edged efficacy lies in the potent Trastuzumab composition. The white to off-white lyophilized powder reconstitutes easily with the provided diluent, ensuring excellent usage flexibility. Its application surface is intravenous, prioritizing patients requiring targeted oncological therapy under expert supervision. This product is available exclusively on prescription.

Delivery Time, Certifications & Port Details

Once ordered, Eleftha 440mg Injection is dispatched promptly, adhering to stringent quality certifications and regulatory approvals. Each vial is carefully packed, valued at global exporter standards, and handed over via verified FOB ports in India. Exporters and suppliers guarantee that your order reaches you in splendid condition, ensuring full traceability and compliance. The overall delivery process is managed to maintain product integrity and timely handover, in line with medical urgency and logistics excellence.

FAQ's of Eleftha 440mg Injection:

Q: How should Eleftha 440mg Injection be stored to maintain its premium quality?

A: Eleftha 440mg Injection must be stored at 2-8C and should never be frozen. Keep the original packaging intact to protect the product from light and maintain its shelf life of up to 36 months.

Q: What is the process for reconstituting Eleftha 440mg Injection before IV infusion?

A: To reconstitute, add the provided diluent to the vial containing the lyophilized powder. Gently swirl until fully dissolved. The solution should appear clear to slightly opalescent before intravenous use. This process should only be performed by qualified healthcare professionals.

Q: Where can Eleftha 440mg Injection be applied for treatment?

A: This injection is indicated for administration in hospital settings, mainly under the supervision of specialists for patients with breast cancer or metastatic gastric cancer.

Q: When is Eleftha 440mg Injection typically administered during cancer therapy?

A: Eleftha 440mg Injection is administered according to a tailored schedule determined by the oncologist, based on the patient's treatment plan, cancer type, and response to prior therapies.

Q: What benefits does Eleftha 440mg Injection offer in cancer treatment?

A: Eleftha 440mg Injection provides targeted therapy using Trastuzumab, known to improve outcomes in HER2-positive breast and gastric cancer, and potentially prolong survival when integrated into a comprehensive cancer treatment plan.

Tell us about your requirement